- Home
- PRZO vs MBIO Comparison
PRZO vs MBIO Comparison
Compare PRZO & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- MBIO
- Stock Information
- Founded
- PRZO 2014
- MBIO 2015
- Country
- PRZO Israel
- MBIO United States
- Employees
- PRZO N/A
- MBIO 80
- Industry
- PRZO
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- MBIO Health Care
- Exchange
- PRZO Nasdaq
- MBIO Nasdaq
- Market Cap
- PRZO 7.8M
- MBIO 7.3M
- IPO Year
- PRZO 2023
- MBIO N/A
- Fundamental
- Price
- PRZO $2.13
- MBIO $5.55
- Analyst Decision
- PRZO
- MBIO Strong Buy
- Analyst Count
- PRZO 0
- MBIO 1
- Target Price
- PRZO N/A
- MBIO $2.00
- AVG Volume (30 Days)
- PRZO 8.6M
- MBIO 468.6K
- Earning Date
- PRZO 09-03-2024
- MBIO 03-10-2025
- Dividend Yield
- PRZO N/A
- MBIO N/A
- EPS Growth
- PRZO N/A
- MBIO N/A
- EPS
- PRZO N/A
- MBIO N/A
- Revenue
- PRZO $558,382.00
- MBIO N/A
- Revenue This Year
- PRZO N/A
- MBIO N/A
- Revenue Next Year
- PRZO N/A
- MBIO N/A
- P/E Ratio
- PRZO N/A
- MBIO N/A
- Revenue Growth
- PRZO N/A
- MBIO N/A
- 52 Week Low
- PRZO $0.49
- MBIO $5.19
- 52 Week High
- PRZO $3.16
- MBIO $76.00
- Technical
- Relative Strength Index (RSI)
- PRZO 56.32
- MBIO 31.43
- Support Level
- PRZO $1.77
- MBIO $5.19
- Resistance Level
- PRZO $2.00
- MBIO $13.30
- Average True Range (ATR)
- PRZO 0.32
- MBIO 2.31
- MACD
- PRZO -0.06
- MBIO -0.47
- Stochastic Oscillator
- PRZO 25.90
- MBIO 2.14
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.